Rodolfo Da Silva Mazzarini Baldinotti

More information in national current research information system (CRIStin)

1: Potenza ML, Blankvoort S, Carvalho MM, Grimstvedt JS, Di Maria V, Moan K,
Nair RR, Flatset MS, Zhang Q, Thomas LF, Pauzin FP, Da Silva Mazzarini
Baldinotti R, Quattrocolo G, Bramham CR, Sætrom P, Witter MP, Kentros CG.
Generation of an enhancer-driven gene expression viral tool specific to dentate
granule cell-types through direct hippocampal injection. Front Neurosci. 2024
Mar 14;18:1274174. doi: 10.3389/fnins.2024.1274174. PMID: 38550563; PMCID:
PMC10976853.

2: Ishizuka Y, Mergiya TF, Baldinotti R, Xu J, Hallin EI, Markússon S, Kursula
P, Bramham CR. Development and Validation of Arc Nanobodies: New Tools for
Probing Arc Dynamics and Function. Neurochem Res. 2022 Sep;47(9):2656-2666. doi:
10.1007/s11064-022-03573-5. Epub 2022 Mar 20. Erratum in: Neurochem Res. 2022
Mar 31;: PMID: 35307777; PMCID: PMC9463278.

3: Fronza MG, Baldinotti R, Fetter J, Rosa SG, Sacramento M, Nogueira CW, Alves
D, Praticò D, Savegnago L. Beneficial effects of QTC-4-MeOBnE in an LPS-induced
mouse model of depression and cognitive impairments: The role of blood-brain
barrier permeability, NF-κB signaling, and microglial activation. Brain Behav
Immun. 2022 Jan;99:177-191. doi: 10.1016/j.bbi.2021.10.002. Epub 2021 Oct 5.
PMID: 34624485.

4: Baldinotti R, Fronza MG, Fetter J, Silva L, Bender CB, Lüdtke DS, Seixas FK,
Collares T, Alves D, Savegnago L. Protective effects of octylseleno-
xylofuranoside in a streptozotocin-induced mouse model of Alzheimer's disease.
Eur J Pharmacol. 2021 Nov 5;910:174499. doi: 10.1016/j.ejphar.2021.174499. Epub
2021 Sep 8. PMID: 34508753.

5: Fronza MG, Baldinotti R, Sacramento M, Gutierres J, Carvalho FB, Fernandes
MDC, Sousa FSS, Seixas FK, Collares T, Alves D, Pratico D, Savegnago L. Effect
of QTC-4-MeOBnE Treatment on Memory, Neurodegeneration, and Neurogenesis in a
Streptozotocin-Induced Mouse Model of Alzheimer's Disease. ACS Chem Neurosci.
2021 Jan 6;12(1):109-122. doi: 10.1021/acschemneuro.0c00615. Epub 2020 Dec 14.
PMID: 33315382.

6: Fronza MG, Baldinotti R, Fetter J, Sacramento M, Sousa FSS, Seixas FK,
Collares T, Alves D, Praticò D, Savegnago L. QTC-4-MeOBnE Rescues Scopolamine-
Induced Memory Deficits in Mice by Targeting Oxidative Stress, Neuronal
Plasticity, and Apoptosis. ACS Chem Neurosci. 2020 May 6;11(9):1259-1269. doi:
10.1021/acschemneuro.9b00661. Epub 2020 Apr 13. PMID: 32227985.

7: Costa GP, Baldinotti RSM, Fronza MG, Nascimento JER, Dias ÍFC, Sonego MS,
Seixas FK, Collares T, Perin G, Jacob RG, Savegnago L, Alves D. Synthesis,
Molecular Docking, and Preliminary Evaluation of 2-(1,2,3-Triazoyl)benzaldehydes
As Multifunctional Agents for the Treatment of Alzheimer's Disease. ChemMedChem.
2020 Apr 3;15(7):610-622. doi: 10.1002/cmdc.201900622. Epub 2020 Mar 12. PMID:
32012463.

8: Fronza MG, Baldinotti R, Martins MC, Goldani B, Dalberto BT, Kremer FS,
Begnini K, Pinto LDS, Lenardão EJ, Seixas FK, Collares T, Alves D, Savegnago L.
Rational design, cognition and neuropathology evaluation of QTC-4-MeOBnE in a
streptozotocin-induced mouse model of sporadic Alzheimer's disease. Sci Rep.
2019 May 13;9(1):7276. doi: 10.1038/s41598-019-43532-9. PMID: 31086208; PMCID:
PMC6513848.

9: Sousa FSS, Birmann PT, Baldinotti R, Fronza MG, Balaguez R, Alves D, Brüning
CA, Savegnago L. α- (phenylselanyl) acetophenone mitigates reserpine-induced
pain-depression dyad: Behavioral, biochemical and molecular docking evidences.
Brain Res Bull. 2018 Sep;142:129-137. doi: 10.1016/j.brainresbull.2018.07.007.
Epub 2018 Jul 20. PMID: 30016730.